Vascular medicine and thrombectomy in stroke
The treatment of stroke caused by intracranial vessel occlusion with intravenous recombinant tissue plasminogen activator (rt-PA) was the only evidence-based treatment option for a long time. Nevertheless the response rate was disappointing in large vessel occlusions. Five studies that evaluated the...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2018-01-01
|
| Series: | Therapeutic Advances in Neurological Disorders |
| Online Access: | https://doi.org/10.1177/1756285617742082 |
| _version_ | 1818042307214049280 |
|---|---|
| author | Sebastian Fischer Werner Weber |
| author_facet | Sebastian Fischer Werner Weber |
| author_sort | Sebastian Fischer |
| collection | DOAJ |
| description | The treatment of stroke caused by intracranial vessel occlusion with intravenous recombinant tissue plasminogen activator (rt-PA) was the only evidence-based treatment option for a long time. Nevertheless the response rate was disappointing in large vessel occlusions. Five studies that evaluated the efficacy of mechanical thrombectomy published in 2015 proved a significant clinical benefit for selected patients suffering from acute ischemic stroke. These results are the basis for extensive technical, institutional, and personal structural changes in the neurovascular field of stroke treatment. This review gives an overview of the current status of mechanical thrombectomy and future expectations and challenges are discussed. |
| first_indexed | 2024-12-10T08:44:14Z |
| format | Article |
| id | doaj.art-9434c9aaf64f45e1ba02f26bfe480871 |
| institution | Directory Open Access Journal |
| issn | 1756-2864 |
| language | English |
| last_indexed | 2024-12-10T08:44:14Z |
| publishDate | 2018-01-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Therapeutic Advances in Neurological Disorders |
| spelling | doaj.art-9434c9aaf64f45e1ba02f26bfe4808712022-12-22T01:55:46ZengSAGE PublishingTherapeutic Advances in Neurological Disorders1756-28642018-01-011110.1177/1756285617742082Vascular medicine and thrombectomy in strokeSebastian FischerWerner WeberThe treatment of stroke caused by intracranial vessel occlusion with intravenous recombinant tissue plasminogen activator (rt-PA) was the only evidence-based treatment option for a long time. Nevertheless the response rate was disappointing in large vessel occlusions. Five studies that evaluated the efficacy of mechanical thrombectomy published in 2015 proved a significant clinical benefit for selected patients suffering from acute ischemic stroke. These results are the basis for extensive technical, institutional, and personal structural changes in the neurovascular field of stroke treatment. This review gives an overview of the current status of mechanical thrombectomy and future expectations and challenges are discussed.https://doi.org/10.1177/1756285617742082 |
| spellingShingle | Sebastian Fischer Werner Weber Vascular medicine and thrombectomy in stroke Therapeutic Advances in Neurological Disorders |
| title | Vascular medicine and thrombectomy in stroke |
| title_full | Vascular medicine and thrombectomy in stroke |
| title_fullStr | Vascular medicine and thrombectomy in stroke |
| title_full_unstemmed | Vascular medicine and thrombectomy in stroke |
| title_short | Vascular medicine and thrombectomy in stroke |
| title_sort | vascular medicine and thrombectomy in stroke |
| url | https://doi.org/10.1177/1756285617742082 |
| work_keys_str_mv | AT sebastianfischer vascularmedicineandthrombectomyinstroke AT wernerweber vascularmedicineandthrombectomyinstroke |